3M delivered a strong finish to 2025, beating expectations with Q4 organic growth of 2.2% and full-year organic sales growth of 2.1%, significantly outperforming the macro environment. Adjusted EPS grew 10% to $8.06 for the year, driven by a 200-basis point expansion in operating margins to 23.4% and robust free cash flow conversion slightly above 100%. The performance was underpinned by successful execution of commercial excellence initiatives, a 68% increase in new product launches (284 products), and operational improvements including OTIF exceeding 90%. Looking ahead to 2026, management raised guidance, projecting organic sales growth of approximately 3%, adjusted EPS of $8.50 to $8.70, and continued margin expansion of 70 to 80 basis points, signaling confidence in their self-help strategies despite persistent macro headwinds in automotive and consumer markets.
| Metric | Value | Change |
|---|---|---|
| Q4 Organic Sales Growth | 2.2% | N/A |
| FY 2025 Organic Sales Growth | 2.1% | +0.9% vs 2024 |
| Q4 Adjusted EPS | $1.83 | +9% |
| FY 2025 Adjusted EPS | $8.06 | +10% |
| FY 2025 Adjusted Operating Margin | 23.4% | +200 bps |
| FY 2025 Free Cash Flow Conversion | >100% | N/A |
| New Product Launches (2025) | 284 | +68% YoY |
| On-Time In-Full (OTIF) Rate | >90% | +300 bps |
Management is aggressively pivoting the portfolio towards 'priority verticals' which now represent a little over 60% of the company and are growing faster than the overall business. Bill Brown indicated that approximately 80% of R&D spend is now aligned to these priority areas, which offer higher growth and margin potential. Conversely, they identified about 10% of the company in 'commodity-like' businesses that may be divested or restructured over time. This strategic shift is designed to structurally improve the company's sustainable organic growth rate and margin profile.
Innovation is reaccelerating with a 68% year-over-year increase in new product launches in 2025 (284 products), and management targets 350 launches in 2026. The 'New Product Vitality Index' (NPVI) reached 13%, and sales from products launched in the last five years grew 23%, exiting the year at 44%. This surge in innovation is a critical driver for the expected 2026 outperformance versus the macro, with management attributing roughly half of their projected $300 million+ market outgrowth to new product introductions.
Operational excellence has become a core competitive advantage, with On-Time In-Full (OTIF) delivery rates exceeding 90% (the best in decades) and Overall Equipment Effectiveness (OEE) improving over 300 basis points. These metrics are not just internal scorecards but are translating into commercial success, helping 3M win shelf space and reduce customer churn. The focus on 'Cost of Poor Quality' (down 100 bps to 6%) and targets to reduce it further to 5.4% in 2026 signal a relentless focus on margin expansion through manufacturing rigor.
The company is evolving from a 'back-to-basics' approach to a 'transformational' phase, shifting from a holding company model to an integrated operating company. This involves reengineering the structural cost base, simplifying business processes, and embedding an 'AI-first' mentality. While the benefits of this transformation are back-end loaded (3-5 year paybacks), management is making investments now ($225 million in growth/productivity investments in 2026) to build a margin runway beyond 2027.
Capital allocation remains a priority, with 3M returning $4.8 billion to shareholders in 2025 through dividends and buybacks. For 2026, they plan to repurchase approximately $2.5 billion in gross shares. This aggressive return of capital, combined with a commitment to maintain a healthy balance sheet, supports the investment thesis even as they invest heavily in the business transformation.
Commercial excellence initiatives are gaining traction, with 600 joint business plans implemented and nearly $50 million in annualized cross-selling wins closed. Management noted that sales force effectiveness and pricing governance have tightened, contributing to the 200 basis point margin expansion in 2025. This discipline allows them to outperform even in a muted demand environment.
The Consumer segment remains a significant weak point, with Q4 organic sales down 2.2% and full-year revenue declining 0.3%. Management attributed this to weak consumer sentiment and sluggish retail traffic. While December showed a double-digit rebound, the trend is volatile, and the guidance for Consumer to return to growth in 2026 relies on a macro recovery that is currently 'subdued,' posing a risk to upside if the consumer remains pressured.
Automotive and auto aftermarket markets continue to soften, with auto builds down 0.3% and the aftermarket remaining weak. This impacts a significant portion of 3M's portfolio. Management noted that auto builds were 'a little weaker in Q4' and are watching this area closely. A prolonged downturn in auto production or repair activity could dampen the growth outlook for the Safety and Industrial, and Transportation and Electronics segments.
Tariff and trade headwinds are escalating. The company faced a $100 million gross tariff impact in 2025 and expects a similar carryover effect in the first half of 2026. Additionally, new potential tariffs on Europe (discussed as a possibility by the administration) could add another $30-40 million headwind. These external costs create a moving target for margin expansion and require constant pricing adjustments to offset.
Litigation and stranded costs continue to weigh on financial flexibility. Management expects litigation costs to remain around $500 million in 2026, similar to 2025 levels. Furthermore, stranded costs are expected to rise from $100 million in 2025 to $150 million in 2026. These persistent 'below the line' or non-operational costs limit the flow-through of operational improvements to net income.
While management is confident in the 3% organic growth guidance for 2026, the macro backdrop is softening. US Industrial Production (IPI) is expected to be flat, and China growth is decelerating from 6% to 4%. The guidance implies a significant 'outgrowth' versus the macro (approx. $300 million+), which relies heavily on the success of new products and commercial execution. Any misstep in execution or a deeper macro slowdown could result in a miss relative to the raised expectations.
Overall: Management exhibited a high degree of confidence and discipline throughout the call, consistently emphasizing the company's ability to 'control the controllables' amidst a soft macro environment. Bill Brown and Anurag Maheshwari sounded assured regarding the operational turnaround, citing specific metrics like OTIF and new product vitality to validate their strategy. There was a notable shift from defensive positioning to offensive growth talk, particularly regarding the pivot to priority verticals and the acceleration of the transformation agenda.
Confidence: HIGH - Management provided specific data points to back up their claims (e.g., OTIF >90%, 284 new product launches, 600 joint business plans). They raised guidance for 2026 and stated they are tracking ahead of Investor Day targets, indicating strong internal conviction in their execution capabilities.
Approximately 3%
$8.50 to $8.70
70 to 80 basis points
Greater than 100%
Approximately $2.5 billion (gross)
Hedging & Uncertainty: Management used hedging language primarily regarding the macro environment, using phrases like 'it is still early to put too much weight on market forecasts' and 'we expect the macro to be similar to 2025.' However, they notably reduced hedging when discussing internal execution, using definitive language such as 'we are tracking ahead,' 'we delivered,' and 'we will continue to execute.' This contrast suggests high confidence in their ability to control internal outcomes despite external uncertainty. Anurag Maheshwari also hedged slightly on the specific impact of new tariffs, stating 'it is a long way from that becoming an executive order,' which tempers immediate investor concern while acknowledging the risk.
Control the controllables - Bill Brown, Chairman and CEO
Tracking ahead of our Investor Day targets - Anurag Maheshwari, Chief Financial Officer
Commercial excellence foundation - Bill Brown, Chairman and CEO
New product vitality index - Bill Brown, Chairman and CEO
Transformational phase - Bill Brown, Chairman and CEO
Priority verticals - Bill Brown, Chairman and CEO
Integrated operating company - Bill Brown, Chairman and CEO
Outperforming the macro - Bill Brown, Chairman and CEO
Pricing governance - Bill Brown, Chairman and CEO
Design-to-cost - Bill Brown, Chairman and CEO
Analyst Sentiment: Analysts were generally inquisitive and focused on the sustainability of the 'self-help' growth versus macro headwinds. Questions probed the specifics of the consumer weakness, the impact of potential new tariffs, and the mechanics of the portfolio pivot towards priority verticals. There was a clear interest in understanding how much of the guidance beat was due to internal execution versus external factors.
Management Responses: Management responses were detailed and data-rich, often breaking down growth drivers into specific buckets like 'commercial excellence' vs 'NPI' (New Product Introductions). Bill Brown was direct about challenges in the consumer and auto segments but consistently steered the conversation back to operational metrics (OTIF, OEE) and the strength of the industrial portfolio. Anurag Maheshwari provided precise financial granularity regarding margin drivers and investment headwinds.
Discussion on the 'Priority Verticals' strategy, specifically the balance between organic investment in these areas versus potential divestitures of commodity businesses (approx. 10% of revenue).
Deep dive into Consumer segment performance, specifically the sharp drop in October/November versus the double-digit rebound in December, and the implications for Q1 2026.
Analysis of pricing strategy, distinguishing between covering inflation/tariffs versus capturing value from new product innovations.
Impact of potential new tariffs between the US and Europe, with management quantifying a potential $30-40 million headwind if enacted.
Clarification on inventory levels in the channel, described as 'normalized' on the industrial side but slightly elevated on the consumer side.
Details on the 'Design-to-Cost' initiative within R&D to ensure new products are competitive in 'mainstream' markets without diluting margins.
3M is demonstrating a successful operational turnaround that is increasingly self-sustaining. The company has effectively pivoted from a period of restructuring to one of execution and growth, evidenced by beating 2025 targets across organic growth, margins, and cash flow. The shift towards an integrated operating model, combined with a revitalized innovation pipeline (284 new products) and rigorous commercial execution (600 joint business plans), provides a clear path to 3%+ organic growth and continued margin expansion in 2026. While macro headwinds in auto and consumer persist, 3M's diversified industrial portfolio and 'control the controllables' mindset position it to outperform the market. The commitment to aggressive capital allocation ($2.5B buybacks planned) adds a layer of shareholder return that enhances the investment case. We view the current valuation as attractive given the visible earnings power and improving structural fundamentals.
Management expects US Industrial Production (IPI) to be flat in 2026 compared to 1% growth in 2025. They noted softening in both the US and China, which impacts the broader demand for industrial products.
Global auto builds are weakening, expected to be down 0.3% for the year. The auto aftermarket remains soft due to lower repair claims, creating a headwind for 3M's Transportation and Electronics segment.
US consumer sentiment is described as 'subdued' with sluggish retail traffic. This led to a 2.2% decline in the Consumer segment in Q4 and a full-year decline of 0.3%.
Growth in China is decelerating. After growing mid-single digits in 2025, management expects China IPI to be down 2% year-over-year in 2026, though they still expect to outperform the local market.
Existing tariffs from 2025 will continue to impact 2026 (approx. $100M headwind). Additionally, new potential tariffs on Europe (10% rising to 25%) pose a risk of an additional $30-40 million impact if enacted.